NPI: 1235191230 · ORANGEBURG, SC 29115 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/05/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR,LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 04/05/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,331 | $105K |
| 2019 | 9,332 | $61K |
| 2020 | 10,338 | $39K |
| 2021 | 3,099 | $4K |
| 2022 | 1,424 | $65.79 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 10,893 | 1,267 | $155K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,998 | 872 | $34K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 69 | 53 | $8K |
| A4657 | Syringe, with or without needle, each | 1,322 | 947 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | 2,129 | 732 | $2K |
| 83970 | 775 | 631 | $1K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,206 | 790 | $587.90 |
| 82108 | 330 | 277 | $291.66 | |
| 82728 | 334 | 281 | $232.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 139 | 90 | $204.03 |
| 83550 | 354 | 297 | $180.68 | |
| 83540 | 355 | 297 | $148.57 | |
| 85045 | 818 | 696 | $148.43 | |
| 85041 | 876 | 771 | $120.35 | |
| 85048 | 872 | 767 | $113.94 | |
| 90674 | 28 | 27 | $31.05 | |
| G0008 | Administration of influenza virus vaccine | 26 | 25 | $0.00 |